E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation

BACKGROUND: E2F1 is the gatekeeper of the cell cycle controlling an analogous balance between proliferation and cell death. E2F1 expression is elevated in advanced prostate cancer. However, it is still unclear that the roles and mechanisms of E2F1 on prostate cancers. METHODS: Targeted knockdown by...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ren, Zijia, Kang, Wenyao, Wang, Lihua, Sun, Baoliang, Ma, Jiajia, Zheng, Chaogu, Sun, Jie, Tian, Zhigang, Yang, Xiaoyi, Xiao, Weihua
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4004456/
https://ncbi.nlm.nih.gov/pubmed/24742333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-13-84
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados